Hepatitis B Immunoglobulin P Behring

Hepatitis B Immunoglobulin P Behring Indications/Uses

hepatitis b immunoglobulin


CSL Behring


Full Prescribing Info
Immunoprophylaxis of hepatitis B in case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown); in haemodialysed patients, until vaccination has become effective; in the newborn of a hepatitis B virus carrier-mother or a mother with unknown HbsAg-status; in subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.
National and/or World Health Organization (WHO) guidelines regarding protection against hepatitis B immunoglobulin should be observed.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in